
NYSE:KEYS
This summary was created by AI, based on 1 opinions in the last 12 months.
Keysight Technologies Inc. (KEYS-N) is distinguished as a leading player in the quantum technology sector, particularly in the middle part of the stack that facilitates data inference in quantum systems. The company is recognized for its measurement solutions, playing a critical role in the testing of chips prior to their market launch. Analysts highlight a positive outlook, with a bullish 12-month price target of $403, suggesting potential for significant growth. While the stock may appear high-priced, it's recommended to consider buying in increments at $340 and $320 to optimize entry points. Despite not offering a dividend, the company's strong positioning in the quantum sector and favorable analyst target merit attention.
Keysight Technologies Inc. is a American stock, trading under the symbol KEYS (previously KEYS-N on Stockchase) on the New York Stock Exchange (KEYS). It is usually referred to as NYSE:KEYS or KEYS
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on KEYS (previously KEYS-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Keysight Technologies Inc..
Keysight Technologies Inc. was recommended as a Top Pick by Kim Bolton on 2026-05-06. Read the latest stock experts ratings for Keysight Technologies Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Keysight Technologies Inc..
Keysight Technologies Inc. is followed by 62 investors on Stockchase and is a trending stock that is worth watching.
On 2026-09-08, Keysight Technologies Inc. (KEYS) stock closed at a price of $333.42.
On the platform part of quantum -- middle part of the stack -- helps quantum make inferences. A measurement company, so it's one of the major players testing chips before they get rolled out.
(Analysts’ price target is $318.62)His 12-month price target is $403. May seem pricey, but keep it on your radar. Buy in thirds here, at $340, and at $320. No dividend.